Likewise, when we tested some of our CD4 T cell-derived TCRs to generate NK-TCR cells, we observed that these cells killed MHC class II+ antigen presenting tumour cells (Mensali, Inderberg and Wälchli et al., unpublished data). Here, CD4 is linked to neoplasm.